openPR Logo
Press release

Biologics Testing Global Market Analysis, Trends, Growth, Research And Forecast 2033

11-20-2024 08:06 AM CET | Energy & Environment

Press release from: The Business research company

Biologics Testing Global Market

Biologics Testing Global Market

The Business Research Company recently released a comprehensive report on the Global Biologics Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

According to The Business Research Company's, The biologics testing market size has grown rapidly in recent years. It will grow from $5.09 billion in 2023 to $5.88 billion in 2024 at a compound annual growth rate (CAGR) of 15.6%. The growth in the historic period can be attributed to growth in biologics development, stringent regulatory standards, quality control in bioprocessing, rise in biopharmaceutical investments, expansion of biomanufacturing capacity.

The biologics testing market size is expected to see rapid growth in the next few years. It will grow to $10.82 billion in 2028 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be attributed to emergence of advanced therapies, increasing demand for contract testing services, expansion of biologics pipelines, globalization of biopharmaceutical manufacturing, increasing demand for rapid testing solutions. Major trends in the forecast period include advanced analytical technologies, cell-based assays, next-generation sequencing (ngs), quality by design (qbd) principles, integration of artificial intelligence (ai), rapid methods for product release.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

Market Drivers and Trends:

The rapidly growing pharmaceutical and biotechnology industries are expected to propel the growth of the biologics testing market going forward. The pharmaceutical industry is primarily focused on developing and manufacturing medications for various diseases and medical conditions. The biotechnology industry, on the other hand, focuses on the application of technology to biology and healthcare. Biologics testing includes tests to identify and quantify impurities, assess stability, and evaluate the immune response to the drug. The growth of the pharmaceutical and biotechnology industries has also led to advances in biologics testing technology, such as the development of new analytical tools and techniques. This has allowed for more accurate and efficient testing, reducing the time and cost of bringing new biologics to market. For instance, in June 2022, according to the European Federation of Pharmaceutical Industries and Associations, a Brussels-based trade association and lobbying organization, the European pharmaceutical production increased by 4.64% from € 286,697 million ($307,416 million) in 2020 to € 300,000 million ($321,681 million) in 2021. Further, in 2021, according to Torys LLP, a Canada-based corporate law firm, 84 initial public offerings for biotech companies in the US in 2020 raised a total of US$15 billion. Therefore, the rapidly growing pharmaceutical and biotechnology industries are driving the growth of the biologics testing market.

Product Innovations are a key trend gaining popularity in the biologics testing market. Companies operating in the biologics testing market are adopting new innovative products to sustain their position in the market. For instance, in December 2022, Charles River Laboratories International, Inc., a US-based non-clinical contract research organization, launched the Endosafe Nexus 200TM, a new addition to its broad endotoxin testing line. The Nexus 200 is a data integrity compliant, fully robotic instrument that is the next step in Charles River's evolution. It uses Endosafe Limulus Amebocyte Lysate (LAL) cartridge technology and can process simple or complex serial dilutions for water, in-process, and final product testing. The system, which is run on Endosafe EndoScan-V version 6.1, enables data to be exported into a Laboratory Information Management System (LIMS) interface and offers enhanced traceability, security, and data management on an integrated touch screen.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=10276&type=smp

Major Key Players of the Market:

Charles River Laboratories Inc.; Thermo Fisher Scientific Inc.; Merck KGaA; SGS Société Générale de Surveillance SA; WuXi AppTec Co. Ltd.; Sartorius AG; Cytovance Biologics Inc.; Pace Analytical Services Inc.; Avance Biosciences Inc.; Celgene Corporation; Biomerieux SA; Lonza Group Ltd.; Genscript Biotech Corp.; Bio-Rad Laboratories Inc.; Accugen Laboratories Inc.; Gibraltar Laboratories Inc.; Jordi Labs; Gilead Sciences Inc.; Bioquell Limited; Southern Research; Promega Corporation; Lancaster Laboratories Inc.; Toxikon Corporation; Eurofins BioPharma Product Testing; Johnson & Johnson Inc.; QIAGEN N.V.; GlaxoSmithKline plc; Danaher Corporation; Agilent Technologies Inc.; PerkinElmer Inc.; Abbott Laboratories; Beckman Coulter Inc.; Becton Dickinson and Company; Roche Holding AG; Novartis AG; Eli Lilly and Company; Pfizer Inc.

Biologics Testing Market 2024 Key Insights:

• The biologics testing market size will grow to $10.82 billion in 2028 at a compound annual growth rate (CAGR) of 16.5%.
• Unleashing Potential In The Thriving Biologics Testing Market Of Pharmaceutical And Biotechnology Advancements
• Exploring The Latest Trends With Product Innovations In The Biologics Testing Market
• North America was the largest region in the biologics testing market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=10276&type=smp

Contact Us:

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biologics Testing Global Market Analysis, Trends, Growth, Research And Forecast 2033 here

News-ID: 3745751 • Views:

More Releases from The Business research company

2025-2034 Electric Wheelchair Market Outlook: Key Drivers, Emerging Challenges, and Strategic Insights
2025-2034 Electric Wheelchair Market Outlook: Key Drivers, Emerging Challenges, …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Electric Wheelchair Industry Market Size Be by 2025? The size of the electric wheelchair market has seen a swift expansion in the last few years. The market size which is projected to be $5.2 billion in 2024 is expected to surge to $5.79 billion in 2025,
2025 Diagnostic Imaging Services Industry Trends Report: Long-Term Outlook Through 2034
2025 Diagnostic Imaging Services Industry Trends Report: Long-Term Outlook Throu …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Diagnostic Imaging Services Market Size By 2025? The market size for diagnostic imaging services has seen a robust growth in the past few years. It is projected to increase from $538.26 billion in 2024 to $566.86 billion in 2025, with a compound annual growth rate
Major Growth Driver Identified in 2025 Biopsy Devices Market: Rising Cancer Incidence Drives Robust Growth In The Biopsy Devices Market
Major Growth Driver Identified in 2025 Biopsy Devices Market: Rising Cancer Inci …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Biopsy Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The biopsy devices market has experienced robust growth in the past few years. It is projected to increase from $3.03 billion in 2024 to $3.24 billion in 2025, with a compound annual growth rate (CAGR)
Increasing Prevalence Of Osteoarthritis In 3D Printed Medical Devices Market Emerges as a Core Driver of the 3D Printed Medical Devices Market in 2025
Increasing Prevalence Of Osteoarthritis In 3D Printed Medical Devices Market Eme …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the 3D Printed Medical Devices Market Through 2025? The market size for 3D printed medical devices has seen explosive growth recently. The market is predicted to expand from its value of $3.32 billion in 2024 to reach $4.1 billion in 2025, showcasing a

All 5 Releases


More Releases for Biologics

Global Biologics Contract Manufacturing Market Set to Reach $83.47 Billion by 20 …
Biologics Contract Manufacturing Market reached US$ 26.03 billion in 2024 and is expected to reach US$ 83.47 billion by 2033, growing at a CAGR of 14.0% during the forecast period 2025-2033. The Biologics Contract Manufacturing market involves outsourcing the production of complex biologic drugs, including vaccines, antibodies, and recombinant proteins. Rising demand for biologics, cost-effective manufacturing, and scalable production drives growth. Technological advancements in cell culture, purification, and quality control enhance
Advanced Biologics Manufacturing Solutions Market Future Business Opportunities …
The qualitative latest Research report (2025-2032) on the Advanced Biologics Manufacturing Solutions Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/137417 Focused on
Biologics Fill Finish Manufacturing Market 2024-2031: Global Industry Size, Shar …
According to a new report published by CoherentMI The Biologics Fill Finish Manufacturing Market is estimated to be valued at USD 5.41 Billion in 2024 and is expected to reach USD 9.04 Billion by 2031, growing at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031. Most recent Report, named "Biologics Fill Finish Manufacturing Market" Patterns, Offer, Size, Development, Opportunity and Forecast 2024-2031, by CoherentMI offers a
Biologics Market
The "Biologics Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Biologics Market, 2024-2031 Verified Market Research's most recent report, "Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the industry
Biologics Contract Manufacturing Market to Witness Huge Growth by 2031 | Wuxi Bi …
The Biologics Contract Manufacturing Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach. Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/biologics-contract-manufacturing-market What is the
Spine Biologics Market Report 2024 - Spine Biologics Market Trends And Share
"The Business Research Company recently released a comprehensive report on the Global Spine Biologics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample